Terumo (OTCMKTS:TRUMY) Shares Pass Below 50-Day Moving Average – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $14.75 and traded as low as $13.50. Terumo shares last traded at $13.67, with a volume of 228,682 shares trading hands.

Terumo Stock Down 0.6%

The firm has a fifty day simple moving average of $14.75 and a 200-day simple moving average of $16.25. The company has a market capitalization of $20.24 billion, a PE ratio of 22.78 and a beta of 0.75. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.46 and a current ratio of 2.51.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.16 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.16. The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.75 billion. Terumo had a net margin of 12.35% and a return on equity of 9.39%.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.